Evidence map›Paper›PMID 34454062›Full record

ArticleBioorganic & medicinal chemistry letters2021

HSymM-guided engineering of the immunodominant p53 transactivation domain putative peptide antigen for improved binding to its anti-p53 monoclonal antibody.

Zachary R Fritz, Rene S Schloss, Martin L Yarmush, Lawrence J Williams

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zachary R FritzDepartment of Biomedical Engineering, Rutgers University, Piscataway, NJ 08854, United States.
Rene S SchlossDepartment of Biomedical Engineering, Rutgers University, Piscataway, NJ 08854, United States.
Martin L YarmushDepartment of Biomedical Engineering, Rutgers University, Piscataway, NJ 08854, United States.
Lawrence J WilliamsDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, United States. Electronic address: Lwilliams@chem.rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

X-RAY STRUCTURE OF RIFM PROTEIN FROM THE BIOSYNTHESIS PATHWAY OF THE ANSAMYCIN AP41RR012408 · NCRR · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MARIUZZA, ROY A · 1998 to 2011
$32.2M
Rutgers Biotechnology Training ProgramT32GM135141 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI ANN M. STOCK, Martin L Yarmush · 2020 to 2026
$3.5M
A Biacore 8K SystemS10OD026750 · OD · RUTGERS, THE STATE UNIV OF N.J. · PI TUMER, NILGUN E · 2019 to 2019
$385k
NCRR NIH HHS P41 RR012408NIGMS NIH HHS T32 GM135141NIH HHS S10 OD026750
6 · The paper itself

Abstract

A novel engineering strategy to improve autoantibody detection with peptide fragments derived from the parent antigen is presented. The model system studied was the binding of the putative p53 TAD peptide antigen (residues 46-55) to its cognate anti-p53 antibody, ab28. Each engineered peptide contained the full decapeptide epitope and differed only in the flanking regions. Since minimal structural information was available to guide the design, a simple epitope:paratope binding model was applied. The Hidden Symmetry Model, which we recently reported, was used to guide peptide design and estimate per-residue contributions to interaction free energy as a function of added C- and N-terminal flanking peptides. Twenty-four peptide constructs were designed, synthesized, and assessed for binding affinity to ab28 by surface plasmon resonance, and a subset of these peptides were evaluated in a simulated immunoassay for limit of detection. Many peptides exhibited over 200-fold enhancements in binding affinity and improved limits of detection. The epitope was reevaluated and is proposed to be the undecapeptide corresponding to residues 45-55. HSymM calculated binding free energy and experimental data were found to be in good agreement (R

Indexed as

Protein EngineeringAntibodies, MonoclonalAntigensHumansImmunodominant EpitopesPeptide FragmentsProtein ConformationTumor Suppressor Protein p53Antibodies, MonoclonalAntigensImmunodominant EpitopesPeptide FragmentsTumor Suppressor Protein p53AntibodyAutoantibodiesCoarse grained modelsEpitopeHidden symmetry modelImmunoassaysp53ParatopePeptide engineeringPeptides

Identifiers

PMID34454062
PMCPMC8526406
OpenAlexW3198751512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.